Literature DB >> 19258709

Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.

Alexander A L Jorge1, Alexsandra C Malaquias, Ivo J P Arnhold, Berenice B Mendonca.   

Abstract

Noonan syndrome (NS) is one of the most common syndromes transmitted by a mendelian mode. In recent years, germline mutations that affect components of the RAS-MAPK (mitogen-activated protein kinase) pathway were shown to be involved in the pathogenesis of NS and four rare syndromes with clinical features overlapping with NS: Leopard syndrome, cardio-facio-cutaneous syndrome, Costello syndrome and neurofibromatosis type 1. Several hormones act through receptors that stimulate the RAS-MAPK pathway, and therefore, NS and related disorders represent a remarkable opportunity to study the implication of the RAS-MAPK pathway in different endocrine systems. Additionally, children with NS frequently are referred to the endocrinologist because of short stature, delayed puberty and/or undescended testes in males. In this paper, we review the diagnostic, clinical and molecular aspects of NS and NS-related disorders. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258709     DOI: 10.1159/000201106

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  28 in total

1.  C4ST-1/CHST11-controlled chondroitin sulfation interferes with oncogenic HRAS signaling in Costello syndrome.

Authors:  Michael Klüppel; Payman Samavarchi-Tehrani; Kela Liu; Jeffrey L Wrana; Aleksander Hinek
Journal:  Eur J Hum Genet       Date:  2012-02-08       Impact factor: 4.246

2.  Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment.

Authors:  Anna Papadopoulou; Michalis Issakidis; Evangelia Gole; Konstantina Kosma; Helen Fryssira; Andreas Fretzayas; Polyxeni Nicolaidou; Sophia Kitsiou-Tzeli
Journal:  Eur J Pediatr       Date:  2011-05-18       Impact factor: 3.183

Review 3.  Giant cell lesions in noonan syndrome: case report and review of the literature.

Authors:  Andreia Bufalino; Manoela Carrera; Roman Carlos; Ricardo D Coletta
Journal:  Head Neck Pathol       Date:  2010-04-11

4.  Noonan syndrome: comparing mutation-positive with mutation-negative dutch patients.

Authors:  E A Croonen; W Nillesen; C Schrander; M Jongmans; H Scheffer; C Noordam; J M T Draaisma; I van der Burgt; H G Yntema
Journal:  Mol Syndromol       Date:  2013-05-08

5.  Pulmonary stenosis as a predisposing factor for infective endocarditis in a patient with Noonan syndrome.

Authors:  Ali Can Hatemi; Mete Gursoy; Aybala Tongut; Burcu Bicakhan; Alper Guzeltas; Gurkan Cetin; Erhan Kansiz
Journal:  Tex Heart Inst J       Date:  2010

Review 6.  Case-only exome sequencing and complex disease susceptibility gene discovery: study design considerations.

Authors:  Lang Wu; Daniel J Schaid; Hugues Sicotte; Eric D Wieben; Hu Li; Gloria M Petersen
Journal:  J Med Genet       Date:  2014-11-04       Impact factor: 6.318

7.  Metachondromatosis: more than just multiple osteochondromas.

Authors:  Thomas J Fisher; Nicole Williams; Lloyd Morris; Peter J Cundy
Journal:  J Child Orthop       Date:  2013-09-21       Impact factor: 1.548

8.  Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype.

Authors:  Heather R Tiffin; Zandra A Jenkins; Mary J Gray; Sophia R Cameron-Christie; Jennifer Eaton; Salim Aftimos; David Markie; Stephen P Robertson
Journal:  Neurogenetics       Date:  2013-03-02       Impact factor: 2.660

9.  Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene.

Authors:  Nara L M Sobreira; Elizabeth T Cirulli; Dimitrios Avramopoulos; Elizabeth Wohler; Gretchen L Oswald; Eric L Stevens; Dongliang Ge; Kevin V Shianna; Jason P Smith; Jessica M Maia; Curtis E Gumbs; Jonathan Pevsner; George Thomas; David Valle; Julie E Hoover-Fong; David B Goldstein
Journal:  PLoS Genet       Date:  2010-06-17       Impact factor: 5.917

10.  A new nonsense mutation in the NF1 gene with neurofibromatosis-Noonan syndrome phenotype.

Authors:  Sevgi Yimenicioğlu; Ayten Yakut; Kadri Karaer; Martin Zenker; Arzu Ekici; Kürşat Bora Carman
Journal:  Childs Nerv Syst       Date:  2012-09-11       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.